A global integrated business enterprise has a US-based, wholly owned subsidiary that is very interested in expanding the healthcare business and increasing its presence in the US. The firm seeks to make engage with early- and mid-stage healthcare companies through strategic investment, partnerships, and more. The firm is open to global opportunities.
Within life sciences and healthcare sectors, the firm is most interested in medical devices, diagnostics, digital health, and healthcare services. Within medtech, the firm focuses on general surgery, laparoscopic surgery, orthopedics, OB/GYN, urology, GI, ENT, respiratory/anesthesia, radiology, and cardiology. In digital health, technologies addressing areas such as virtual care providers, wellness management, etc. that could benefit the aging population are of interest. The firm is can partner with companies across a wide stage of development, from companies still developing a prototype to those who are already on the market. The firm does not invest in biotech or pharmaceutical companies.
The firm has no specific company or management team requirements. The firm is interested in companies who are looking to enter the Asian market, and can help support the companies in navigating regulatory hurdles by leveraging their own regulatory team. The firm can act as a lead or co-investor.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment